StockDrifts LogoStockDrifts

Theragen Etex 066700

Company
테라젠이텍스Theragen Etex
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-01-18

Theragen Etex (066700) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Theragen Etex is dated 2025-03-15; the most recent is 2026-01-18.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-18BUY행사가액조정
박시홍
Park Sihong
CEO72.6K₩1,888+6.5%₩137M ($95K)
2026-01-18SELL행사가액조정
박시홍
Park Sihong
CEO-19.8K₩2,870+1.1%₩57M ($40K)
2025-10-18BUY행사가액조정
박시홍
Park Sihong
CEO19.8K₩2,605+9.0%₩52M ($36K)
2025-04-18BUYCB인수
박시홍
Park Sihong
CEO169.5K₩2,990-5.0%₩507M ($352K)
2025-03-15BUY기타
고재훈
Jaehoon Go
-170.3K₩3,130-9.3%₩533M ($370K)
2025-03-15BUY제3자배정유상증자
고진업
Gojinup
CEO Chairman899.6K₩3,130-9.3%₩2.8B ($2.0M)
2025-03-15BUY제3자배정유상증자
고재훈
Jaehoon Go
-3.6M₩3,130-9.3%₩11.3B ($7.8M)

Frequently asked questions

Who has been buying Theragen Etex stock?
0 distinct insiders have filed 0 disclosed insider purchases in Theragen Etex (066700), most recently on 2026-01-18. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Theragen Etex have?
Theragen Etex has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-03-15 to 2026-01-18.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.